Kim Rivers Sells 139,846 Shares of Trulieve Cannabis (NYSE:TRLV) Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 139,846 shares of the firm’s stock in a transaction on Thursday, June 18th. The stock was sold at an average price of $9.46, for a total value of $1,322,943.16. Following the completion of the sale, the chief executive officer directly owned 2,898,539 shares of the company’s stock, valued at approximately $27,420,178.94. This trade represents a 4.60% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Price Performance

Shares of TRLV stock opened at $8.59 on Wednesday. Trulieve Cannabis Corp. has a 1-year low of $3.25 and a 1-year high of $13.28.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Weiss Ratings assumed coverage on Trulieve Cannabis in a report on Tuesday, June 16th. They issued a “sell (d-)” rating on the stock. Zacks Research upgraded shares of Trulieve Cannabis to a “hold” rating in a report on Thursday, June 18th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Trulieve Cannabis currently has an average rating of “Reduce”.

About Trulieve Cannabis

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.